HomeCompareULIHF vs GBDC

ULIHF vs GBDC: Dividend Comparison 2026

ULIHF yields 4.61% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ULIHF wins by $3893.53M in total portfolio value· pulled ahead in Year 5
10 years
ULIHF
ULIHF
● Live price
4.61%
Share price
$1.30
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3914.38M
Annual income
$3,757,849,931.79
Full ULIHF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — ULIHF vs GBDC

📍 ULIHF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodULIHFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ULIHF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ULIHF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ULIHF
Annual income on $10K today (after 15% tax)
$392.01/yr
After 10yr DRIP, annual income (after tax)
$3,194,172,442.02/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, ULIHF beats the other by $3,180,189,318.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ULIHF + GBDC for your $10,000?

ULIHF: 50%GBDC: 50%
100% GBDC50/50100% ULIHF
Portfolio after 10yr
$1967.62M
Annual income
$1,887,150,332.82/yr
Blended yield
95.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

ULIHF
No analyst data
Altman Z
2.5
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ULIHF buys
0
GBDC buys
0
No recent congressional trades found for ULIHF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricULIHFGBDC
Forward yield4.61%11.86%
Annual dividend / share$0.06$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%51.1%
Portfolio after 10y$3914.38M$20.85M
Annual income after 10y$3,757,849,931.79$16,450,733.83
Total dividends collected$3903.33M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ULIHF vs GBDC ($10,000, DRIP)

YearULIHF PortfolioULIHF Income/yrGBDC PortfolioGBDC Income/yrGap
1$11,622$922.37$12,492$1,791.70$870.00GBDC
2$14,440$2,003.76$16,527$3,160.58$2.1KGBDC
3$20,104$4,653.23$23,588$5,904.90$3.5KGBDC
4$33,620$12,109.28$37,141$11,901.65$3.5KGBDC
5← crossover$73,826$37,852.07$66,205$26,463.38+$7.6KULIHF
6$234,355$155,361.26$137,452$66,612.65+$96.9KULIHF
7$1,172,599$921,838.97$342,372$195,298.53+$830.2KULIHF
8$9,876,061$8,621,381.00$1,053,292$686,954.33+$8.82MULIHF
9$146,291,644$135,724,258.55$4,111,439$2,984,416.95+$142.18MULIHF
10$3,914,381,991$3,757,849,931.79$20,849,974$16,450,733.83+$3893.53MULIHF

ULIHF vs GBDC: Complete Analysis 2026

ULIHFStock

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Full ULIHF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this ULIHF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ULIHF vs SCHDULIHF vs JEPIULIHF vs OULIHF vs KOULIHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.